WASHINGTON (AP) -- Medicare spending on breakthrough medications for hepatitis C will nearly double this year, passing $9 billion, according to new government figures. Thatamp;apos;s raising insurance costs for all beneficiaries, whether or not they have the liver-wasting viral disease....